Osteopore Limited (ASX:OSX)
0.0140
0.00 (0.00%)
Jun 10, 2025, 4:10 PM AEST
Osteopore Company Description
Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Malaysia, the Netherlands, Thailand, Australia, and internationally.
The company commercializes products designed to enable natural bone healing across multiple therapeutic areas.
Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material.
The company manufactures and trades medical implants; sells medical devices; provides technology services; and engages in research and development activities.
Osteopore Limited was founded in 2003 and is headquartered in Singapore.
Osteopore Limited

Country | Australia |
Founded | 2003 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
CEO | Yujing Lim |
Contact Details
Address: 2 Tukang Innovation Grove #09-06/07 Singapore, 6000 Singapore | |
Phone | 61 2 8072 1400 |
Website | osteopore.com |
Stock Details
Ticker Symbol | OSX |
Exchange | Australian Securities Exchange |
Fiscal Year | January - December |
Reporting Currency | AUD |
ISIN Number | AU0000053324 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Dr. Yujing Lim | Chief Executive Officer, Chief Technology Officer and Executive Director |
Kei Wei Leong | Executive Chairman |
Shu Ning Voon | Financial Controller |
Khoon Seng Goh | Global Marketing Director |
Jack Rosagro | Company Secretary |